Literature DB >> 19034126

Effect of hypotonic 0.4% hyaluronic acid drops in dry eye patients: a cross-over study.

Pasquale Troiano1, Gaspare Monaco.   

Abstract

PURPOSE: The aim of the study is to evaluate the short-term effects of 2 kinds of artificial tears, both containing 0.4% hyaluronic acid in an aqueous solution yet having different osmolarity, on the typical symptoms of patients suffering from dry eye and on the vitality of corneal and conjunctival epithelial cells.
METHODS: A cross-over, randomized, balanced, single-blind study involving 28 patients was divided into 2 treatment groups: group A (unpreserved 0.4% hyaluronic acid eye drops 300 mOsm/L) and group B (unpreserved 0.4% hyaluronic acid eye drops 150 mOsm/L). Both treatments were administered for 7 days, being dosed as a 1 solution drop 4 times daily. After a 1-day wash-out period, the patients in group A passed over to group B and vice versa.
RESULTS: Treatment with hypotonic solution gave better results in relieving symptoms, along with a statistically significant improvement (P < 0.001) in the state of the corneoconjunctival epithelium, than the isotonic solution. At the end of the study, 60.7% of the patients declared that they preferred hypotonic solution and only 10.7% preferred isotonic solution; the remaining 28.6% did not notice any difference between the 2 treatments.
CONCLUSIONS: By reducing the osmolarity of tear film, the hypotonic solution not only improves the characteristics of tear film and the vitality of the epithelial cells of the cornea and conjunctiva but also proves to be effective in reducing dry eye symptoms.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19034126     DOI: 10.1097/ICO.0b013e318180e55c

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  20 in total

1.  Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells.

Authors:  Masahiko Ayaki; Atsuo Iwasawa; Yoshimi Niwano
Journal:  Jpn J Ophthalmol       Date:  2011-08-10       Impact factor: 2.447

2.  Treating Sjögren's Syndrome: Insights for the Clinician.

Authors:  Claudio Vitali; Gianluigi Palombi; Pierluigi Cataleta
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-06       Impact factor: 5.346

Review 3.  The role of fibronectin in corneal wound healing explored by a physician-scientist.

Authors:  Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2012-07-27       Impact factor: 2.447

4.  Synergistic Properties of Arabinogalactan (AG) and Hyaluronic Acid (HA) Sodium Salt Mixtures.

Authors:  Antonia Di Mola; Francesco Ferdinando Summa; Patrizia Oliva; Francesco Lelj; Stefano Remiddi; Ludovica Silvani; Antonio Massa
Journal:  Molecules       Date:  2021-11-29       Impact factor: 4.411

5.  Isotonic Glycerol and Sodium Hyaluronate Containing Artificial Tear Decreases Conjunctivochalasis after One and Three Months: A Self-Controlled, Unmasked Study.

Authors:  Huba J Kiss; János Németh
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

6.  Effects of a Hyaluronic Acid/Hydroxypropyl Guar Artificial Tear Solution on Protection, Recovery, and Lubricity in Models of Corneal Epithelium.

Authors:  Rekha Rangarajan; Brian Kraybill; Abayomi Ogundele; Howard A Ketelson
Journal:  J Ocul Pharmacol Ther       Date:  2015-06-11       Impact factor: 2.671

7.  Effectiveness of sodium hyaluronate eye gel in patients with dry eye disease: a multi-centre, open label, uncontrolled study.

Authors:  Nasir Saeed; Za Qazi; Nadeem H Butt; Ahson Siddiqi; Neeta Maheshwary; Muhammad Athar Khan
Journal:  Pak J Med Sci       Date:  2013-07       Impact factor: 1.088

8.  Comparison of the Anti-Inflammatory Effects of Artificial Tears in a Rat Model of Corneal Scraping.

Authors:  Philippe Daull; Laurence Feraille; Pierre-Paul Elena; Jean-Sébastien Garrigue
Journal:  J Ocul Pharmacol Ther       Date:  2016-01-11       Impact factor: 2.671

9.  Purification and biocompatibility of fermented hyaluronic acid for its applications to biomaterials.

Authors:  Sungchul Choi; Woncheol Choi; Sekweon Kim; Su-Yeon Lee; Insup Noh; Chan-Wha Kim
Journal:  Biomater Res       Date:  2014-06-13

10.  Use of preservative-free hyaluronic acid (Hylabak(®)) for a range of patients with dry eye syndrome: experience in Russia.

Authors:  Vladimir Vsevolodovich Brjesky; Yury Fedorovich Maychuk; Alexey Vladimirovich Petrayevsky; Peter Gerrievich Nagorsky
Journal:  Clin Ophthalmol       Date:  2014-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.